Abstract
A treatment strategy of a difficult and unusual problem is presented. We are reporting a case of a patient who had a documented allergy to heparin and required Cardiac surgery for an ASD closure. The anticoagulation regime used during cardiopulmonary bypass was lepirudin based. This report indicates that r-hirudin provides effective anticoagulation, however unless ECT is monitoring, post operative hemorrhage is encountered. Therefore this case is unique not only because of its rarity but also by the fact that it presents the caveats encountered when ECT is not available. © 2011 Parissis; licensee BioMed Central Ltd.
Cite
CITATION STYLE
Parissis, H. (2011). Lepirudin as an alternative to “heparin allergy” during cardiopulmonary bypass. Journal of Cardiothoracic Surgery, 6(1). https://doi.org/10.1186/1749-8090-6-44
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.